As unusual as it may seem for some people, sometimes indicators of diseases may lie in what we flush out of our bodies, like our stools. The color may be an indicator of something as serious as stomach cancer.
One of the types of cancer that plague a portion of the world’s population is stomach cancer. While it is not as prevalent as the other types such as lung cancer, it is still serious and must be treated before it gets worse. Express reports that an indicator that a person may have the disease is in the color of the stool. The color of the stool usually indicates how healthy a person is, and in this case, if the stool is very dark, almost black in color, then it may be a symptom of stomach cancer.
Then again, the color of the stool may also be affected by the medication being taken as well as the kind of food or drinks being eaten. According to Cancer Research UK, a person’s stool may also be the same dark, almost-black color if they take iron tablets.
At the same time, blood in the stool may also indicate the disease. However, as with any illness, these symptoms may be indicators for other diseases so it is still best to check with a physician, who can give a proper test. The symptoms of stomach cancer may also overlap with symptoms of stomach ulcers or other conditions that may not be as serious.
Meanwhile, there are kinds of food that do affect the color of the stools. Seeing a different color may seem alarming but before the panic sets in, it is also good to think about what kind of food you may have eaten. Beets may affect the color of the stool and turn it into a dark red color, almost like blood.
In case the stool in the toilet is of a greenish hue, then veggies are the likely cause. Green stools are usually harmless and do not really indicate serious issues, such as diarrhea, salmonella infections, and stomach cramps. Blueberries may also be the cause of a blueish tinge in the stool.


Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 



